Non-interventional study on the safety and efficacy of an Abraxane(R) mono therapy for the therapy of patients with metasasized breast cancer with special consideration of the toxicity profiles.
Phase of Trial: Phase IV
Latest Information Update: 10 Sep 2016
At a glance
- Drugs Paclitaxel (Primary)
- Indications Advanced breast cancer
- Focus Therapeutic Use
- Acronyms Abraham
- 06 Jul 2012 Actual initiation date (1 Sep 2011) added as reported by German Clinical Trials Register record.
- 06 Sep 2011 New trial record